Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 22, 2024Cancer Research

Post-Transplant Bone Marrow Immune Dysregulation in Multiple Myeloma

View Full Paper
Ask AI
Bookmark
Share

Authors

JWJulia T. WangMFMark A. FialaKSKazuhito Sato

Discussion

Loading...

Member takes

Overview

Observational analysis reveals immune microenvironment signatures linked to progression-free survival in multiple myeloma, indicating post-transplant immune dysregulation impacts outcomes.

Key Points

  • Post-transplant bone marrow immune profiling demonstrates specific T cell and myeloid shifts that correlate with multiple myeloma survival.
  • Across samples, progression-free survival ranged from 10 months to over 7 years, with myeloid-derived suppressor cells linked to worse outcomes.
  • Analysis using single-cell RNA sequencing evaluated 49 newly diagnosed and 79 day-100 post-transplant whole bone marrow aspirates from patients.

Cite This Study

Wang et al. (2024) studied this question.

synapsesocial.com/papers/68e72e32b6db6435876a7a48https://doi.org/10.1158/1538-7445.am2024-6881
View Full Paper
Ask AI
Bookmark
Share